SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-139500
Filing Date
2021-11-16
Accepted
2021-11-15 21:00:50
Documents
13
Period of Report
2021-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2133040d1_8k.htm   iXBRL 8-K 27617
2 EXHIBIT 99.1 tm2133040d1_ex99-1.htm EX-99.1 61771
  Complete submission text file 0001104659-21-139500.txt   278908

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ptpi-20211115.xsd EX-101.SCH 3201
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptpi-20211115_lab.xml EX-101.LAB 34594
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptpi-20211115_pre.xml EX-101.PRE 22721
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2133040d1_8k_htm.xml XML 3734
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39752 | Film No.: 211413811
SIC: 2834 Pharmaceutical Preparations